Related Experiment Video
Updated: Feb 12, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice
Jimmy Jianheng Zhou1,2, Yuan Min Wang1, Vincent W S Lee2,3
1Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.
Abstract:
Studies disrupting the chemokine pathway CX3CL1 (fractalkine)/ CX3CR1 have shown decreased atherosclerosis in animal models but the techniques used to interrupt the pathway have not been easily translatable into human trials. DNA vaccination potentially overcomes the translational difficulties. We evaluated the effect of a DNA vaccine, targeted to CX3CR1, on atherosclerosis in a murine model and examined possible mechanisms of action. DNA vaccination against CX3CR1, enhanced by dendritic cell targeting using DEC-205 single chain variable region fragment (scFv), was performed in 8 week old ApoE-/- mice, fed a normal chow diet. High levels of anti-CX3CR1 antibodies were induced in vaccinated mice. There were no apparent adverse reactions to the vaccine. Arterial vessels of 34 week old mice were examined histologically for atherosclerotic plaque size, macrophage infiltration, smooth muscle cell infiltration and lipid deposition. Vaccinated mice had significantly reduced atherosclerotic plaque in the brachiocephalic artery. There was less macrophage infiltration but no significant change to the macrophage phenotype in the plaques. There was less lipid deposition in the lesions, but there was no effect on smooth muscle cell migration. Targeted DNA vaccination to CX3CR1 was well tolerated, induced a strong immune response and resulted in attenuated atherosclerotic lesions with reduced macrophage infiltration. DNA vaccination against chemokine pathways potentially offers a potential therapeutic option for the treatment of atherosclerosis.
Insights
DNA vaccination targeting the CX3CR1 chemokine receptor reduced atherosclerosis in mice. This approach, which induced high antibody levels without adverse effects, offers a promising therapeutic strategy for atherosclerosis.
Area of Science:
- Immunology
- Cardiovascular Research
- Molecular Medicine
Background:
- Chemokine CX3CL1 (fractalkine)/CX3CR1 pathway disruption shows promise in reducing atherosclerosis in animal models.
- Existing methods for pathway interruption lack easy translation to human clinical trials.
- DNA vaccination presents a potential solution to overcome translational difficulties.
Purpose of the Study:
- To evaluate the efficacy of a DNA vaccine targeting CX3CR1 in a murine model of atherosclerosis.
- To investigate the underlying mechanisms of action for CX3CR1 DNA vaccination.
- To assess the safety and immunogenicity of the targeted DNA vaccine.
Main Methods:
- DNA vaccination against CX3CR1, enhanced with dendritic cell targeting (DEC-205 scFv), administered to 8-week-old ApoE-/- mice.
- Mice were fed a normal chow diet.
- Histological examination of arterial vessels at 34 weeks for atherosclerotic plaque size, macrophage infiltration, smooth muscle cell infiltration, and lipid deposition.
Main Results:
- High levels of anti-CX3CR1 antibodies were induced, with no apparent adverse reactions.
- Significantly reduced atherosclerotic plaque in the brachiocephalic artery of vaccinated mice.
- Reduced macrophage infiltration and lipid deposition in lesions, with no significant change in macrophage phenotype or smooth muscle cell migration.
Conclusions:
- Targeted DNA vaccination against CX3CR1 is well-tolerated and elicits a robust immune response.
- This vaccination strategy leads to attenuated atherosclerotic lesions and reduced macrophage infiltration.
- DNA vaccination targeting chemokine pathways represents a potential therapeutic avenue for atherosclerosis treatment.
Related Concept Videos
Vaccinations
DC Generator
DC Battery
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Fast Decoupled and DC Powerflow
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...

